11.05.24 -- Comparing In-house Vs. Outsourced Manufacturing Strategies For CGTs

PMs must be technically adept enough to understand a project, but their main role is to ensure it delivers in terms of scope and budget.

Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.

Review four key factors for improving on-time delivery when outsourcing drug product manufacturing and discover how investing in building a solid relationship with your CDMO improves timelines.

Unlocking the potential of next-generation therapeutics requires extending the boundaries of both expression system technology and process development and manufacturing.

Using a contract or toll manufacturer in the specialty and custom chemical industry can be viewed as a quality and supply chain risk. Learn what equipment sourcing strategies can mitigate those risks.

Finding partners with the necessary skills to optimize AAV processes is crucial for minimizing risk. Explore key considerations for advancing your therapy from concept to commercialization.

A miscalculated analytical approach can be costly to develop, perform, and maintain. Many organizations also lack appropriate resources to create optimal testing methods and protocols.

If you’re looking to work with a CDMO that can help you save money and ensure efficiency in your therapeutic production, consider the benefits of choosing a Polish partner.

 An embedded CMO offers many advantages over other CMO models, not least its access to the extensive capabilities and knowhow of the parent organization.

Ultimately, by prioritizing quality, biotech companies can ensure a smoother development process, safeguard patient well-being, and ultimately bring life-saving treatments to market faster.

Explore how a CMO with innovative practices and a successful approach to tech transfer and manufacturing processes can help meet project timelines and mitigate risk on the path to market.

Intensified adherent cell culture offers a promising solution to the limitations of traditional suspension culture, with the potential to improve efficiency, reduce costs, and accelerate development.

Learn innovative strategies to overcome the complexities of bispecific antibody development, from intelligent design to efficient purification techniques.

Immune cell therapies have incredible potential for cancer treatment, and making them more cost effective is a critical consideration for improving patient access and outcomes.